文献速递免疫规划

三价肺炎球菌蛋白疫苗在婴儿小鼠模型中预防肺炎链球菌所致实验性急性中耳炎

Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model.
PubMed 文献 · Vaccine · 2016-12-03

在婴儿C57BL/6J小鼠模型中,1-3周龄肌内接种单价PhtD、PcpA、PlyD1或三价肺炎球菌蛋白重组疫苗(PPrV),7-8周龄经鼓膜接种肺炎链球菌攻击。三价PPrV显著降低中耳液细菌负荷并减轻炎症细胞因子水平,对不可分型菌株也有类似保护。

要点

  • 三价PPrV在婴儿小鼠中诱导对应蛋白的血清IgG抗体应答。
  • 三价PPrV显著降低中耳液肺炎链球菌负荷(24h p=0.001,48h p<0.0001)。
  • 接种小鼠中耳炎症细胞因子水平显著较低(均p<0.05)。

核心结论

  • 三价PPrV在婴儿小鼠模型中提供针对肺炎球菌性急性中耳炎的保护。

研究设计与样本

  • 婴儿C57BL/6J小鼠模型:1-3周龄肌内接种单价PhtD、PcpA、PlyD1或三价PPrV,7-8周龄经鼓膜接种1×10² CFU肺炎链球菌株BG7322(6A)或1×10⁴ CFU不可分型株0702064MEF。
  • 采用ELISA测定血清IgG滴度,感染后24和48小时处死动物收集中耳液(MEF)测定肺炎球菌CFU。

主要发现

  • 单价和三价肺炎球菌蛋白疫苗接种婴儿小鼠均诱导对应组分蛋白的显著血清IgG抗体应答。
  • PhtD接种组MEF细菌负荷在24小时(p=0.05)和48小时(p=0.16)均降低。
  • PcpA接种组MEF细菌负荷在24小时(p=0.02)和48小时(p=0.004)显著降低,PlyD1接种组在48小时(p=0.02)显著降低。
  • 三价PPrV接种组MEF肺炎链球菌负荷在24小时(p=0.001)和48小时(p<0.0001)均显著降低;以不可分型菌株攻击时也观察到类似细菌负荷降低。
  • 接种小鼠中耳在感染后24小时的炎症细胞因子(IL-1β、IL-6、TNF-α、MIP-2和KC)水平显著较低(所有p值<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Currently licensed serotype-based pneumococcal vaccines are effective in preventing invasive pneumococcal diseases, but less effective in preventing non-bacteremic pneumonia and acute otitis media (AOM). We previously reported that a trivalent pneumococcal protein recombinant vaccine (PPrV) protected against pneumonia in a murine model. Here we evaluated PPrV protection against AOM in an infant murine model. METHODS: C57BL/6J mice were intramuscularly vaccinated at 1-3weeks of age with monovalent pneumococcal histidine triad protein D (PhtD), or pneumococcal choline binding protein A (PcpA), or detoxified pneumolysin (PlyD1), or trivalent vaccine, and transtympanically challenged at 7-8weeks of age with 1×102CFU of pneumococcal strain BG7322 (6A) or 1×104CFU of pneumococcal nontypeable strain 0702064MEF. Serum IgG titers were determined by ELISA. At 24 and 48h post infection (hpi), animals were sacrificed and middle ear fluid (MEF) samples were collected to determine pneumococcal CFUs. RESULTS: We found that vaccination of infant mice with monovalent and trivalent pneumococcal proteins elicited significant serum IgG antibody responses to corresponding component proteins. Vaccination with PhtD reduced BG7322 bacterial burdens in MEF at both 24 (p=0.05) and 48hpi (p=0.16). Vaccination with PcpA significantly reduced the bacterial burdens in MEF at both 24 (p=0.02) and 48hpi (p=0.004), and PlyD1 significantly reduced bacterial burden in MEF at 48hpi (p=0.02). Vaccination with trivalent PPrV (PhtD, PcpA and PlyD1) significantly reduced Spn burdens in MEF at both 24 (p=0.001) and 48hpi (p<0.0001). Similar reductions of bacterial burdens were found when the vaccinated animals were challenged with a non-typeable Spn strain. Vaccinated mice had significantly milder inflammatory cytokine levels (IL-1β, IL-6, TNF-α, MIP-2 and KC) in middle ears at 24hpi (all p values<0.05). CONCLUSION: Trivalent PPrV confers protection against pneumococcal AOM in an infant murine model.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Xu Q, Pryharski K, Pichichero ME, et al. Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model. Vaccine. 2016. PMID: 27919628. doi:10.1016/j.vaccine.2016.11.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。